Verition Fund Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Verition Fund Management's ATRC Position: Q1 2026 in Review
Verition Fund Management sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 11,301 shares — an estimated $447K sold.
Verition Fund Management first reported a position in ATRC in Q4 2021 and held it in 7 quarters. The position peaked at $14.5M in Q1 2025. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.
- Verition Fund Management reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
- Verition Fund Management sold 11,301 AtriCure shares in Q1 2026, an estimated $447K.
- Verition Fund Management first reported a position in AtriCure in Q4 2021 and held it in 7 quarters.
- Verition Fund Management's AtriCure position peaked at $14.5M in Q1 2025.
- 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.
Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.